4-(4,4-Dimethyl-2,5-dioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile

CAS : 143782-20-1

Ref. TR-D143780

Informations sur le produit

• Nom: 4-(4,4-Dimethyl-2,5-dioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile
• Synonymes: 4-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-2-trifluoromethylbenzonitrile, RU 56279

Description

Applications 4-(4,4-Dimethyl-2,5-dioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile is an intermediate in the synthesis of Oxo-MDV 3100 (Oxo-enzalutamide) (O857800), which is an impurity of Enzalutamide (M199800), which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer.
References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); Ma, X., et al.: J. Pharm. Biomed. Anal., 131, 436 (2016);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 297.23
• Formule: C₁₃H₁₀F₃N₃O₂
• Couleur/Forme: Neat
• InChI: InChI=1S/H3N/h1H3
• Code InChI: InChIKey=QGZKDVFQNNGYKY-UHFFFAOYSA-N
• SMILES: CC1(C)NC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O